vs

Side-by-side financial comparison of HERITAGE FINANCIAL CORP (HFWA) and PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB). Click either name above to swap in a different company.

HERITAGE FINANCIAL CORP is the larger business by last-quarter revenue ($66.3M vs $44.6M, roughly 1.5× PACIFIC BIOSCIENCES OF CALIFORNIA, INC.). HERITAGE FINANCIAL CORP runs the higher net margin — 33.5% vs -90.4%, a 123.9% gap on every dollar of revenue. On growth, HERITAGE FINANCIAL CORP posted the faster year-over-year revenue change (16.3% vs 13.8%). HERITAGE FINANCIAL CORP produced more free cash flow last quarter ($85.7M vs $-19.9M). Over the past eight quarters, HERITAGE FINANCIAL CORP's revenue compounded faster (16.8% CAGR vs 7.3%).

Heritage Financial Corp (WA) is a U.S. regional financial holding company headquartered in Washington state. It provides comprehensive commercial and consumer banking services, including deposit products, small business loans, residential mortgages, personal lending and wealth management solutions, primarily serving local communities across the Pacific Northwest, with core customer segments covering small-to-medium enterprises and retail clients.

Pacific Biosciences of California, Inc. is an American biotechnology company founded in 2004 that develops and manufactures systems for gene sequencing and some novel real time biological observation. PacBio has two principal sequencing platforms: single-molecule real-time sequencing (SMRT), based on the properties of zero-mode waveguides and sequencing by binding (SBB) chemistry, which uses native nucleotides and scarless incorporation for DNA binding and extension.

HFWA vs PACB — Head-to-Head

Bigger by revenue
HFWA
HFWA
1.5× larger
HFWA
$66.3M
$44.6M
PACB
Growing faster (revenue YoY)
HFWA
HFWA
+2.5% gap
HFWA
16.3%
13.8%
PACB
Higher net margin
HFWA
HFWA
123.9% more per $
HFWA
33.5%
-90.4%
PACB
More free cash flow
HFWA
HFWA
$105.6M more FCF
HFWA
$85.7M
$-19.9M
PACB
Faster 2-yr revenue CAGR
HFWA
HFWA
Annualised
HFWA
16.8%
7.3%
PACB

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
HFWA
HFWA
PACB
PACB
Revenue
$66.3M
$44.6M
Net Profit
$22.2M
$-40.4M
Gross Margin
37.1%
Operating Margin
38.7%
-92.3%
Net Margin
33.5%
-90.4%
Revenue YoY
16.3%
13.8%
Net Profit YoY
86.4%
-1802.7%
EPS (diluted)
$0.65
$-0.11

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
HFWA
HFWA
PACB
PACB
Q4 25
$66.3M
$44.6M
Q3 25
$65.7M
$38.4M
Q2 25
$56.5M
$39.8M
Q1 25
$57.6M
$37.2M
Q4 24
$57.1M
$39.2M
Q3 24
$54.8M
$40.0M
Q2 24
$56.4M
$36.0M
Q1 24
$48.6M
$38.8M
Net Profit
HFWA
HFWA
PACB
PACB
Q4 25
$22.2M
$-40.4M
Q3 25
$19.2M
$-38.0M
Q2 25
$12.2M
$-41.9M
Q1 25
$13.9M
$-426.1M
Q4 24
$11.9M
$2.4M
Q3 24
$11.4M
$-60.7M
Q2 24
$14.2M
$-173.3M
Q1 24
$5.7M
$-78.2M
Gross Margin
HFWA
HFWA
PACB
PACB
Q4 25
37.1%
Q3 25
41.4%
Q2 25
36.9%
Q1 25
-3.7%
Q4 24
25.6%
Q3 24
25.0%
Q2 24
16.5%
Q1 24
29.1%
Operating Margin
HFWA
HFWA
PACB
PACB
Q4 25
38.7%
-92.3%
Q3 25
34.0%
-101.1%
Q2 25
25.6%
-112.8%
Q1 25
28.1%
-1154.5%
Q4 24
28.6%
-390.1%
Q3 24
23.8%
-160.3%
Q2 24
28.4%
-488.3%
Q1 24
14.1%
-209.6%
Net Margin
HFWA
HFWA
PACB
PACB
Q4 25
33.5%
-90.4%
Q3 25
29.2%
-98.9%
Q2 25
21.6%
-105.4%
Q1 25
24.2%
-1146.8%
Q4 24
20.9%
6.0%
Q3 24
20.8%
-151.9%
Q2 24
25.1%
-481.3%
Q1 24
11.8%
-201.4%
EPS (diluted)
HFWA
HFWA
PACB
PACB
Q4 25
$0.65
$-0.11
Q3 25
$0.55
$-0.13
Q2 25
$0.36
$-0.14
Q1 25
$0.40
$-1.44
Q4 24
$0.34
$-0.44
Q3 24
$0.33
$-0.22
Q2 24
$0.41
$-0.64
Q1 24
$0.16
$-0.29

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
HFWA
HFWA
PACB
PACB
Cash + ST InvestmentsLiquidity on hand
$233.1M
$279.5M
Total DebtLower is stronger
Stockholders' EquityBook value
$921.5M
$5.3M
Total Assets
$7.0B
$784.1M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
HFWA
HFWA
PACB
PACB
Q4 25
$233.1M
$279.5M
Q3 25
$245.5M
$298.7M
Q2 25
$254.1M
$314.7M
Q1 25
$248.7M
$343.1M
Q4 24
$117.1M
$389.9M
Q3 24
$175.6M
$471.1M
Q2 24
$113.8M
$509.8M
Q1 24
$189.6M
$561.9M
Stockholders' Equity
HFWA
HFWA
PACB
PACB
Q4 25
$921.5M
$5.3M
Q3 25
$904.1M
$36.1M
Q2 25
$888.2M
$61.5M
Q1 25
$881.5M
$91.6M
Q4 24
$863.5M
$506.6M
Q3 24
$874.5M
$453.1M
Q2 24
$850.5M
$492.7M
Q1 24
$847.6M
$649.0M
Total Assets
HFWA
HFWA
PACB
PACB
Q4 25
$7.0B
$784.1M
Q3 25
$7.0B
$803.2M
Q2 25
$7.1B
$825.5M
Q1 25
$7.1B
$860.8M
Q4 24
$7.1B
$1.3B
Q3 24
$7.2B
$1.5B
Q2 24
$7.1B
$1.5B
Q1 24
$7.1B
$1.7B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
HFWA
HFWA
PACB
PACB
Operating Cash FlowLast quarter
$94.8M
$-19.1M
Free Cash FlowOCF − Capex
$85.7M
$-19.9M
FCF MarginFCF / Revenue
129.1%
-44.6%
Capex IntensityCapex / Revenue
13.8%
1.9%
Cash ConversionOCF / Net Profit
4.26×
TTM Free Cash FlowTrailing 4 quarters
$149.0M
$-114.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
HFWA
HFWA
PACB
PACB
Q4 25
$94.8M
$-19.1M
Q3 25
$25.1M
$-18.7M
Q2 25
$22.5M
$-29.4M
Q1 25
$19.3M
$-44.1M
Q4 24
$64.5M
$-30.6M
Q3 24
$24.2M
$-45.5M
Q2 24
$6.8M
$-54.3M
Q1 24
$12.9M
$-75.7M
Free Cash Flow
HFWA
HFWA
PACB
PACB
Q4 25
$85.7M
$-19.9M
Q3 25
$24.4M
$-18.8M
Q2 25
$20.9M
$-29.9M
Q1 25
$18.1M
$-45.4M
Q4 24
$61.0M
$-32.3M
Q3 24
$23.2M
$-46.3M
Q2 24
$6.0M
$-55.7M
Q1 24
$12.0M
$-79.6M
FCF Margin
HFWA
HFWA
PACB
PACB
Q4 25
129.1%
-44.6%
Q3 25
37.1%
-48.9%
Q2 25
37.0%
-75.3%
Q1 25
31.4%
-122.3%
Q4 24
107.0%
-82.3%
Q3 24
42.4%
-115.7%
Q2 24
10.6%
-154.8%
Q1 24
24.7%
-205.0%
Capex Intensity
HFWA
HFWA
PACB
PACB
Q4 25
13.8%
1.9%
Q3 25
1.0%
0.2%
Q2 25
2.8%
1.4%
Q1 25
2.0%
3.7%
Q4 24
6.1%
4.1%
Q3 24
1.7%
2.0%
Q2 24
1.5%
4.1%
Q1 24
1.8%
10.0%
Cash Conversion
HFWA
HFWA
PACB
PACB
Q4 25
4.26×
Q3 25
1.31×
Q2 25
1.84×
Q1 25
1.38×
Q4 24
5.41×
-12.93×
Q3 24
2.12×
Q2 24
0.48×
Q1 24
2.24×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

HFWA
HFWA

Segment breakdown not available.

PACB
PACB

Products$39.0M87%
Service And Other$5.7M13%

Related Comparisons